(0.00%) 5 213.50 points
(-0.01%) 39 025 points
(0.00%) 18 199 points
(-0.74%) $77.80
(0.05%) $2.21
(-0.04%) $2 323.30
(0.04%) $27.56
(-0.06%) $987.80
(0.12%) $0.931
(0.41%) $10.94
(0.16%) $0.801
(0.06%) $91.50
Quarter results tomorrow
(bmo 2024-05-09)
Expected move: +/- 4.75%
-0.74% $ 28.28
@ $28.54
Emitido: 7 may 2024 @ 09:32
Retorno: -0.91%
Señal anterior: may 6 - 15:12
Señal anterior:
Retorno: 0.30 %
Live Chart Being Loaded With Signals
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States...
Stats | |
---|---|
Volumen de hoy | 2.39M |
Volumen promedio | 2.83M |
Capitalización de mercado | 12.75B |
EPS | $0 ( 2024-02-15 ) |
Próxima fecha de ganancias | ( $0.960 ) 2024-05-09 |
Last Dividend | $0.200 ( 2023-11-16 ) |
Next Dividend | $0 ( N/A ) |
P/E | 11.18 |
ATR14 | $0.485 (1.72%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-28 | Fernandez Henry A | Buy | 1 240 | Class A Ordinary Shares |
2024-03-28 | Bassler Bonnie L | Buy | 1 240 | Class A Ordinary Shares |
2024-02-20 | Riggs Rory B | Buy | 300 000 | Class A Ordinary Shares |
2024-02-20 | Riggs Rory B | Sell | 30 000 | LP interests in RPI US Partners 2019, LP |
2024-01-02 | Riggs Rory B | Sell | 235 200 | Class A Ordinary Shares |
INSIDER POWER |
---|
-36.00 |
Last 100 transactions |
Buy: 3 308 362 | Sell: 7 318 226 |
Volumen Correlación
Royalty Pharma plc Correlación
10 Correlaciones Más Positivas | |
---|---|
INCR | 0.957 |
MYSZ | 0.939 |
SPFI | 0.937 |
BMRA | 0.933 |
WATT | 0.931 |
CUTR | 0.93 |
CSSEP | 0.925 |
BWB | 0.919 |
EVLO | 0.918 |
TIVC | 0.918 |
10 Correlaciones Más Negativas | |
---|---|
ESCA | -0.946 |
AMTBB | -0.945 |
BRLI | -0.945 |
GRIL | -0.944 |
ARIZ | -0.941 |
CNGL | -0.94 |
GBRG | -0.936 |
LQDA | -0.934 |
EMLD | -0.934 |
LMRKO | -0.93 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Royalty Pharma plc Correlación - Moneda/Commodity
Royalty Pharma plc Finanzas
Annual | 2023 |
Ingresos: | $2.35B |
Beneficio Bruto: | $1.79B (76.19 %) |
EPS: | $2.54 |
FY | 2023 |
Ingresos: | $2.35B |
Beneficio Bruto: | $1.79B (76.19 %) |
EPS: | $2.54 |
FY | 2022 |
Ingresos: | $2.24B |
Beneficio Bruto: | $2.23B (99.75 %) |
EPS: | $0.0978 |
FY | 2021 |
Ingresos: | $2.29B |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $0.922 |
Financial Reports:
No articles found.
Royalty Pharma plc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.190 (N/A) |
$0.190 (N/A) |
$0.200 (N/A) |
$0.200 (N/A) |
$0.200 (N/A) |
$0.200 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.150 | 2020-09-14 |
Last Dividend | $0.200 | 2023-11-16 |
Next Dividend | $0 | N/A |
Payout Date | 2023-12-15 | |
Next Payout Date | N/A | |
# dividends | 14 | -- |
Total Paid Out | $2.54 | -- |
Avg. Dividend % Per Year | 1.17% | -- |
Score | 4.72 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 6.40 | |
Div. Directional Score | 8.70 | -- |
Year | Amount | Yield |
---|---|---|
2020 | $0.300 | 0.67% |
2021 | $0.680 | 1.45% |
2022 | $0.760 | 1.93% |
2023 | $0.800 | 2.03% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Royal | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.482 | 1.500 | 0.360 | 0.540 | [0 - 0.5] |
returnOnAssetsTTM | 0.0693 | 1.200 | 7.69 | 9.23 | [0 - 0.3] |
returnOnEquityTTM | 0.182 | 1.500 | 9.09 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.316 | -1.000 | 6.84 | -6.84 | [0 - 1] |
currentRatioTTM | 7.90 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 7.87 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 2.96 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.375 | -1.500 | 3.76 | -5.64 | [0 - 0.6] |
interestCoverageTTM | 7.98 | 1.000 | 8.15 | 8.15 | [3 - 30] |
operatingCashFlowPerShareTTM | 6.70 | 2.00 | 7.77 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 1.964 | 2.00 | 9.02 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.940 | -1.500 | 6.24 | -9.36 | [0 - 2.5] |
grossProfitMarginTTM | 0.697 | 1.000 | 1.719 | 1.719 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.634 | 1.000 | 10.00 | 10.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.488 | 1.000 | 8.40 | 8.40 | [0.2 - 2] |
assetTurnoverTTM | 0.144 | 0.800 | -2.38 | -1.900 | [0.5 - 2] |
Total Score | 11.00 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 11.21 | 1.000 | 8.97 | 0 | [1 - 100] |
returnOnEquityTTM | 0.182 | 2.50 | 9.41 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 1.964 | 2.00 | 9.35 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 2.84 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 6.70 | 2.00 | 7.77 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.316 | 1.500 | 6.84 | -6.84 | [0 - 1] |
pegRatioTTM | 0 | 1.500 | -3.33 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 1.271 | 1.000 | 10.00 | 0 | [0.1 - 0.5] |
Total Score | 6.40 |
Royalty Pharma plc
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neurology, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico